|1||Active, not recruiting||
Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults
|2||Active, not recruiting||
Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.
† Study has passed its completion date and status has not been verified in more than two years.